✦ LIBER ✦

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH

✍ Scribed by De Benedetti, F; Ruperto, N; Zuber, Z; Cuttica, R; Xavier, R; Calvo, I; Rubio, N; Alekseeva, E; Chasnyk, V; Chavez, J; Horneff, G; Opoka-Winiarska, V; Quartier, P; Spindler, A; Keane, C; Bharucha, K; Wang, J; Lovell, D; Martini, A; Brunner, HI

Book ID: 121593254
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 110 KB
Volume: 11
Category: Article
ISSN: 1546-0096
DOI: 10.1186/1546-0096-11-S2-O15

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PReS-FINAL-2180: Efficacy and safety of

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH

✍ De Benedetti, F; Ruperto, N; Zuber, Z; Cuttica, R; Xavier, R; Calvo, I; Rubio, N 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 110 KB

Efficacy and safety of tocilizumab (TCZ)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

✍ Fabrizio De Benedetti,Hermine Brunner,Nicola Ruperto,R Cuttica… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 105 KB

Safety and efficacy of tocilizumab, an a

Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis

✍ Tomoyuki Imagawa; Shumpei Yokota; Masaaki Mori; Takako Miyamae; Syuji Takei; Hir 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 368 KB

Safety and efficacy of tocilizumab, an a

Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis

✍ Imagawa, Tomoyuki; Yokota, Shumpei; Mori, Masaaki; Miyamae, Takako; Takei, Syuji 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 379 KB

PReS-FINAL-2134: Assessment of radiograp

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial

✍ Malattia, C; Ruperto, N; Palmisani, E; Pederzoli, S; Pistorio, A; Brunner, HI; C 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 107 KB

PReS-FINAL-2161: Safety and effectivenes

PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to =4 years weighing

✍ Kingsbury, D; Quartier, P; Arora, V; Kalabic, J; Kupper, H; Mozaffarian, N 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 105 KB